News

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...
Led by a founding member of Google Life Sciences, Identifeye Health believes noninvasive retinal scans will reveal much more ...
The prevalence of vision-threatening retinopathy in people with diabetes has increased exponentially in the past decade, most acutely among younger adults and Hispanic and Black populations, an ...
New blood vessels in your eye can signal eye disease. This is called neovascularization, and it’s often a sign of diabetes-related retinopathy. When your body makes new blood vessels in places they ...
LONDON – Long-established, but often forgotten, primary care tools, including the swinging light test and the lipid-lowering drug fenofibrate, may help detect early worsening of diabetic retinopathy ...
While rapid weight-loss with bariatric surgery or drugs might temporarily worsen diabetic retinopathy as blood sugar levels are rapidly corrected, the low overall risk likely doesn't outweigh the ...
Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being diagnosed with type 1 or type 2 diabetes. But since the chronic condition can ...
Type 2 diabetes is among the top causes of vision loss and blindness across the world. According to studies, visual impairment due to diabetic retinopathy has increased significantly in the last 20 ...
A study reveals similar risks of sight-threatening diabetic retinopathy in pregnant women with type 1 diabetes compared to ...
Please provide your email address to receive an email when new articles are posted on . Danegaptide could be an oral therapy for patients with moderate to severe nonproliferative diabetic retinopathy.
BOSTON--(BUSINESS WIRE)--OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology company developing innovative drugs to treat ophthalmic diseases for which the current standard of ...